Billy Evans, former partner of Theranos founder Elizabeth Holmes, is leading a startup called Haemanthus that aims to use lasers for disease detection. The company has reportedly raised up to $20 million and secured at least one patent for its technology, which utilizes Raman spectroscopy. However, Haemanthus has yet to publicly release a product or present data demonstrating its effectiveness, and it has lost its chief technology officer. AI
IMPACT Potential for AI-driven diagnostics, but current lack of product and data raises questions about its viability.
RANK_REASON Article discusses a startup with patents and investors but no product, drawing parallels to Theranos.
- Billy Evans
- Evans Hotels
- Forbes
- Haemanthus
- Lance Oppenheim
- Luminar Technologies
- MIT
- Nathan Fielder
- Raman spectroscopy
- The New York Times
- Theranos
- You Can See Everything
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →